Market size, growth to 2033 and clinical trials, side by side.
The US is the bigger Digital diabetes care market: $5.4 Bn against $1 Bn in 2023, about 5.3 times as large.
Canada grows faster: 19.3% a year, against 17.3%. The gap still grows from $4.4 Bn to $20.6 Bn by 2033.
Clinical research: 331 active trials in the US, 58 in Canada.
| Measure | ||
|---|---|---|
| Market size, 2023 | $5.4 Bn | $1 Bn |
| Market size, 2033 projected | $26.6 Bn | $6 Bn |
| Growth a year (CAGR) | 17.3% | 19.3% |
| Money added, 2023–2033 | $21.2 Bn | $5 Bn |
| Share of the world market | 42% | 8% |
| Size rank of 24 countries | #1 | #3 |
| Market per person, 2023 | $16 | $25 |
| Active clinical trials | 331 | 58 |
| Diabetes (adults) % of adults (WHO) | 12.5 2022 | 6.8 2022 |
| Full report | US report | Canada report |
US Canada · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
The US is the bigger Digital diabetes care market: $5.4 Bn against $1 Bn in 2023, about 5.3 times as large.
Canada grows faster: 19.3% a year, against 17.3%. The gap still grows from $4.4 Bn to $20.6 Bn by 2033.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Health figures: WHO. Population: World Bank.